BSE Live
Oct 10, 16:01Prev. Close
5263.35
Open Price
5233.70
Bid Price (Qty.)
5180.00 (75)
Offer Price (Qty.)
5341.00 (2)
NSE Live
Oct 10, 15:55Prev. Close
5266.50
Open Price
5255.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5333.00 (4)
Profit & Loss account of Pfizer (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2,151.51 | 2,081.42 | 1,980.15 | 2,041.85 | 2,093.69 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 11.68 | 75.67 | 81.42 | |
Revenue From Operations [Net] | 2,151.51 | 2,081.42 | 1,968.47 | 1,966.18 | 2,012.27 | |
Total Operating Revenues | 2,151.65 | 2,081.50 | 1,968.51 | 1,966.26 | 2,012.34 | |
Other Income | 184.02 | 167.39 | 114.29 | 101.16 | 86.99 | |
Total Revenue | 2,335.67 | 2,248.89 | 2,082.80 | 2,067.42 | 2,099.33 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 345.21 | 343.65 | 302.52 | 387.54 | 373.11 | |
Purchase Of Stock-In Trade | 483.81 | 495.13 | 409.65 | 424.70 | 362.09 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -36.62 | -90.88 | 27.51 | -15.76 | 51.89 | |
Employee Benefit Expenses | 364.51 | 323.84 | 314.29 | 303.89 | 277.34 | |
Finance Costs | 10.85 | 1.29 | 0.42 | 0.96 | 0.52 | |
Depreciation And Amortisation Expenses | 103.24 | 71.39 | 66.25 | 62.93 | 57.93 | |
Other Expenses | 422.18 | 444.56 | 414.25 | 516.76 | 515.91 | |
Total Expenses | 1,693.18 | 1,588.98 | 1,534.89 | 1,681.02 | 1,638.79 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 642.49 | 659.91 | 547.91 | 386.40 | 460.54 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 130.43 | 9.89 | |
Profit/Loss Before Tax | 642.49 | 659.91 | 547.91 | 516.83 | 470.42 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 177.70 | 243.77 | 194.49 | 188.66 | 187.81 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.16 | -12.91 | -6.65 | -8.61 | -22.37 | |
Tax For Earlier Years | -44.50 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 133.36 | 230.86 | 187.84 | 180.05 | 165.44 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 509.13 | 429.05 | 360.07 | 336.78 | 304.98 | |
Profit/Loss From Continuing Operations | 509.13 | 429.05 | 360.07 | 336.78 | 304.98 | |
Profit/Loss For The Period | 509.13 | 429.05 | 360.07 | 336.78 | 304.98 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | |
Diluted EPS (Rs.) | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 124.09 | 110.30 | 110.12 | 82.59 | 68.83 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 3,300.00 | 225.00 | 200.00 | 200.00 | 150.00 |
03.10.2025
Why Pfizer struck a drug-pricing deal with the Trump administration
01.10.2025
Trump unveils 'TrumpRx' website for cheaper drugs, Pfizer promises up to 50% discounts | Explained
22.09.2025
14.08.2025
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
30.07.2024
Pfizer Standalone June 2024 Net Sales at Rs 562.86 crore, up 5.93% Y-o-Y
20.05.2024
Pfizer Standalone March 2024 Net Sales at Rs 546.63 crore, down 4.54% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011